American Journal of Clinical Dermatology
Overview
The American Journal of Clinical Dermatology is a peer-reviewed medical journal that focuses on the diagnosis, treatment, and management of various dermatological conditions. It publishes high-quality research articles, reviews, and case reports, providing valuable insights into the latest advancements in clinical dermatology. The journal serves as a trusted resource for dermatologists, researchers, and healthcare professionals seeking evidence-based information to enhance patient care and improve outcomes in dermatology.
Details
Details
Abbr.
Am J Clin Dermatol
Start
2000
End
Continuing
Frequency
Bimonthly
p-ISSN
1175-0561
e-ISSN
1179-1888
Country
New Zealand
Language
English
Specialty
Dermatology
Metrics
Metrics
h-index / Ranks: 2769
107
SJR / Ranks: 763
2631
CiteScore / Ranks: 917
12.20
JIF / Ranks: 805
7.3
Recent Articles
1.
Chovatiya R, Ribero S, Wollenberg A, Park C, Silvestre J, Hong H, et al.
Am J Clin Dermatol
. 2025 Mar;
PMID: 40085349
Background And Objective: There is a need for long-term atopic dermatitis (AD) treatments that can effectively improve AD involvement of the head and neck (H&N) region (referred to as H&N...
2.
Kaltchenko M, Chien A
Am J Clin Dermatol
. 2025 Mar;
PMID: 40072791
Photoaging is the consequence of chronic exposure to solar irradiation, encompassing ultraviolet (UV), visible, and infrared wavelengths. Over time, this exposure causes cumulative damage, leading to both aesthetic changes and...
3.
Cao S, Li W, Wang Z, Li H, Huai P, Chu T, et al.
Am J Clin Dermatol
. 2025 Mar;
PMID: 40059256
Background: There are limited data on clinical outcomes and prognosis factors for bullous pemphigoid (BP) at long-term follow-up. Objective: We aimed to investigate the clinical outcomes and prognostic factors in...
4.
Ronnstad A, Bunick C, Chovatiya R, Kamata M, Nielsen M, Isufi D, et al.
Am J Clin Dermatol
. 2025 Mar;
PMID: 40045152
Background: Tralokinumab, a first-in-class and second biologic approved for treating moderate-to-severe atopic dermatitis in adolescents and adults, has demonstrated consistent efficacy and safety across multiple clinical trials. Objective: We aimed...
5.
Leo F, Ortoncelli M, Cascio Ingurgio R, Galli B, Grigolato L, Paganini C, et al.
Am J Clin Dermatol
. 2025 Feb;
PMID: 39994105
Background: Atopic dermatitis (AD) is a chronic inflammatory skin condition that significantly impairs the quality of life. Recent advancements in systemic therapies, such as Janus kinase (JAK) inhibitors, offer very...
6.
Kim D, Yang S, Gill M, Babaei N, Cervantes M, Wu J
Am J Clin Dermatol
. 2025 Feb;
PMID: 39982633
Innovations in biologics are transforming the treatment of psoriatic diseases. The ability to target specific levels of immune activation provides a distinct advantage. Interleukin (IL)-17 inhibitors fall into this class...
7.
Dagenet C, Atluri S, Ma E, Tong L, Tran K, Hekmatjah J, et al.
Am J Clin Dermatol
. 2025 Feb;
PMID: 39946084
No abstract available.
8.
Tong Z, Zeng X, Huang F, Wu Z, Chen H, Zhang Y, et al.
Am J Clin Dermatol
. 2025 Feb;
PMID: 39939577
Background: The effectiveness of Janus kinase (JAK) inhibitors in treating atopic dermatitis (AD) is well established. However, little is known about whether disease control can be maintained with longer dosing...
9.
Dobre A, Nedelcu R, Turcu G, Brinzea A, Struna I, Tudorache G, et al.
Am J Clin Dermatol
. 2025 Feb;
26(2):305.
PMID: 39924617
No abstract available.
10.
Napolitano M, Esposito M, Fargnoli M, Girolomoni G, Romita P, Nicoli E, et al.
Am J Clin Dermatol
. 2025 Feb;
26(2):183-197.
PMID: 39915363
Atopic dermatitis (AD) is a T helper 2-mediated chronic inflammatory skin disease that affects children and adults. Patients with AD are prone to recurrent infections of the skin and other...